Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Fri Jun 5, 7:00AM CDT

STOUGHTON, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc.  (Nasdaq: COLL) today announced it awarded inducement grants on June 1, 2026 under the Company's 2026 Inducement Plan...

COLL : 34.64 (+0.87%)
COLL
2 Reasons to Sell COLL and 1 Stock to Buy Instead StockStory - Tue Jun 2, 11:05PM CDT

2 Reasons to Sell COLL and 1 Stock to Buy Instead

COLL : 34.64 (+0.87%)
Collegium to Participate in 2026 Jefferies Global Healthcare Conference GlobeNewswire - Wed May 27, 7:00AM CDT

STOUGHTON, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc.  (Nasdaq: COLL) today announced that its management will participate in a fireside chat at the 2026 Jefferies Global...

COLL : 34.64 (+0.87%)
GATX
3 Growth Stocks We’re Skeptical Of StockStory - Mon May 25, 11:31PM CDT

3 Growth Stocks We’re Skeptical Of

GH : 131.62 (+0.55%)
COLL : 34.64 (+0.87%)
GATX : 174.57 (+1.36%)
COLL
Collegium Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions StockStory - Thu May 14, 12:38AM CDT

Collegium Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions

COLL : 34.64 (+0.87%)
TMO
Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know StockStory - Wed May 13, 12:15PM CDT

Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know

COLL : 34.64 (+0.87%)
TMO : 469.34 (-1.33%)
XRAY : 10.09 (-0.49%)
HALO : 69.50 (-1.74%)
Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics GlobeNewswire - Tue May 12, 6:31AM CDT

– Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegium’s Existing ADHD Portfolio – – Extends Collegium’s Long-Term Revenue Outlook; AZSTARYS...

COLL : 34.64 (+0.87%)
GMED
1 Healthcare Stock with Competitive Advantages and 2 We Brush Off StockStory - Sun May 10, 11:34PM CDT

1 Healthcare Stock with Competitive Advantages and 2 We Brush Off

COLL : 34.64 (+0.87%)
GMED : 80.39 (-0.16%)
PRVA : 23.43 (+0.30%)
COLL
COLL Q1 Deep Dive: ADHD Portfolio Expansion and Pain Segment Stability Drive Results StockStory - Fri May 8, 12:40AM CDT

COLL Q1 Deep Dive: ADHD Portfolio Expansion and Pain Segment Stability Drive Results

COLL : 34.64 (+0.87%)
MarketBeat.com
Collegium Pharmaceutical Q1 Earnings Call Highlights MarketBeat - Thu May 7, 12:42PM CDT

Collegium Pharmaceutical (NASDAQ:COLL) reported first-quarter 2026 results highlighting continued growth in its ADHD franchise led by JORNAY PM, steady performance from its pain portfolio, and progress...

COLL : 34.64 (+0.87%)

Barchart Exclusives

XPeng Is Getting Serious About Physical AI as Its CEO Takes Over the Robotics Division Barchart - 11 minutes ago
XPeng is set to mass-produce its humanoid robots under the leadership of its CEO. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.